Liguzinediol对阿霉素诱导的慢性心衰大鼠心功能的影响
Effects of Liguzinediol on Hemodynamics in Chronic Heart Failure Rats Induced by Doxorubicin
-
摘要: 目的 通过阿霉素(Dox)复制大鼠慢性心力衰竭(CHF)模型,观察Liguzinediol对CHF大鼠心功能的影响。方法 通过血流动力学观察Liguzinediol对Dox(腹腔注射,2 mg/kg)诱导的CHF大鼠左心室内压最大上升/下降速率(±dp/dtmax)、左心室内压(LVSP)、动脉收缩压(ASP)、动脉舒张压(ADP)和心率(HR)的变化;观察Liguzinediol对血清一氧化氮(NO)、一氧化氮合成酶(NOS)、超氧化物歧化酶(SOD)、肿瘤坏死因子-α(TNF-α)和白细胞介素-6(IL-6)以及血浆中丙二醛(MDA)的影响。结果 Liguzinediol能增加LVSP、+dp/dtmax、ASP、ADP、AP、HR,降低-dp/dtmax(P<0.05~0.01);降低NO、iNOS以及MDA的浓度,同时增强了SOD的活性(P<0.05~0.01);抑制IL-6和TNF-α的生成(P<0.05~0.01)。结论 Liguzinediol可明显改善Dox诱导的CHF大鼠血流动力学指标,减少模型大鼠炎症因子的释放以及抑制氧自由基的生成。
-
关键词:
- Liguzinediol /
- 慢性心力衰竭 /
- 阿霉素 /
- 心功能
Abstract: OBJECTIVE To explore the effect of Liguzinediol on cardiac function, ventricular remodeling and inflammation in chronic heart failure (CHF) rat model induced by doxorubicin (Dox). METHODS The hemodynamic changes in the maximum ascending/descending rate of left ventricular pressure (+dp/dtmax), left ventricular pressure (LVSP), arterial systolic pressure (ASP), arterial diastolic pressure (ADP) and heart rate (HR) were recorded by multichannel physiological recorder with intragastric administration of Liguzinediol in CHF rats induced by Dox (intraperitoneal injection, 2 mg/kg). The effects of Liguzinediol on oxygen free radicals (NO, NOS, SOD, MDA) and inflammatory factors (IL-6 and TNF-α) were also detected by the kits. RESULTS Liguzinediol increased the levels of LVSP, +dp/dtmax, ASP, ADP, AP and HR, and decreased the level of -dp/dtmax(P<0.05,P<0.01). Liguzinediol decreased the concentration of NO, iNOS and MDA , increased the activity of SOD, and inhibited the contents of IL-6 and TNF-α(P<0.05,P<0.01). CONCLUSION Liguzinediol can improve ventricular remodeling by reducing the release of inflammatory factors, inhibiting the formation of oxygen free radicals.-
Key words:
- Liguzinediol /
- chronic heart failure /
- doxorubicin /
- cardiac function
-
[1] 蔡建国, 李伟, 钱程博,等. Liguzinediol的合成工艺优化[J]. 南京中医药大学学报, 2018, 34(3):322-324. [2] 徐建虎,张琦,杨子庆,等.阿霉素诱导大鼠慢性心衰模型的制备[J].宁夏医科大学学报, 2016, 38(3):348-351. [3] 李文文, 徐斌, 童静,等. Liguzinediol对普罗帕酮诱导的急性心衰大鼠心功能的影响[J]. 南京医科大学学报, 2018,38(11):1506-1511,1524. [4] 郭瑶, 周静, 卞慧敏, 等. 川芎嗪衍生物liguzinediol对戊巴比妥钠致急性心力衰竭大鼠血流动力学的影响[J]. 中国实验方剂学杂志, 2012, 18(6):170-174. [5] 翟淑波, 孙景辉, 郭放. 充血性心力衰竭发病机制的研究进展[J]. 临床儿科杂志, 2006, 24(10):851-853. [6] KNAAPEN MW, DAVIES MJ, DE BM, et al. Apoptotic versus autophagic cell death in heart failure[J]. Cardiovasc Res, 2001, 51(2):304-312. [7] WANG S, KONOREV EA, KOTAMRAJU S, et al. Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. intermediacy of H2O2- and p53-dependent pathways[J]. J Biol Chem, 2004, 279(24):25535-25543. [8] AKAO M, O'ROURKE B, TESHIMA Y, et al. Mechanistically distinct steps in the mitochondrial death pathway triggered by oxidative stress in cardiac myocytes[J]. Circ Res, 2003, 92(2):186-194. [9] 金春花, 刘文博, 关宏锏,等. 一氧化氮合酶各种亚型的信号通路对心力衰竭的作用机制与治疗的研究进展[J]. 中国循环杂志, 2017, 32(8):830-832. [10] MIHM MJ, YU F, WEINSTEIN DM, et al. Intracellular distribution of peroxynitrite during doxorubicin cardiomyopathy: Evidence for selective impairment of myofibrillar creatine kinase[J]. Br J Pharmacol, 2002, 135(3):581-588. [11] CHICCO AJ, SCHNEIDER CM, HAYWARD R. Voluntary exercise protects against acute doxorubicin cardiotoxicity in the isolated perfused rat heart[J]. Am J Physiol Regul Integr Comp Physiol, 2005, 289(2):R424-R431. [12] GIELEN S, ADAMS V, MOBIUSWINKLER S, et al. Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure[J]. J Am Coll Cardiol, 2003, 42(5):861-868.
点击查看大图
计量
- 文章访问数: 640
- HTML全文浏览量: 13
- PDF下载量: 688
- 被引次数: 0